Lonza Group upgrades growth model: what it means for Lonza Group stock
Published on 10/17/2026 at 10:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGrowth targets and coming dates
- Lonza upgraded its organic growth model on October 14, 2026, targeting 10 to 13 percent growth.
- The company reiterated a 2026 core EBITDA margin outlook of 33 to 34 percent.
- The next Xetra session is scheduled for October 19, 2026.
Market context: Market report SMI.
Lonza Group upgraded its organic growth model on October 14, 2026, and said its third-quarter 2026 performance was in line with expectations across all business platforms. The company set a model of 10 to 13 percent organic sales growth at constant exchange rates over time and an ambition to reach a core EBITDA margin in the high thirties over the medium term.
The week in figures
Lonza reiterated its full-year 2026 outlook of 11 to 12 percent constant-exchange-rate sales growth and a core EBITDA margin of 33 to 34 percent. It also reiterated an expected negative foreign-exchange impact of approximately 2 to 3 percent on 2026 sales growth.
The next price is shown from the start of trading by the continuously updated real-time quote of Lonza Group stock.
Chronology of the week
On October 12, 2026, Lonza Group AG announced an exclusive license agreement with Qurient for the use of CDK7 inhibitors in dual-payload antibody-drug conjugate applications. The collaboration adds the SYN-duo CC platform to Lonza’s technology offering.
On October 14, 2026, Lonza announced the upgraded growth model and provided a qualitative third-quarter update. The company said its transformation into a focused pure-play contract development and manufacturing organization was complete.
Dates of the coming week
The next Xetra session is scheduled for October 19, 2026. Lonza’s October 14 update remains the latest dated company announcement in the reviewed period.
